Accessibility Menu
PharmaTher logo

PharmaTher

(OTC) PHRRF

Current Price$0.04
Market Cap$3.83M
Since IPO (2020)-77%
5 Year-91%
1 Year-72%
1 Month-24%

PharmaTher Financials at a Glance

Market Cap

$3.83M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$1.10M

EPS (TTM)

-$0.01

P/E Ratio

-4.78

Dividend

$0.00

Beta (Volatility)

0.41 (Low)

Price

$0.04

Volume

113,397

Open

$0.04

Previous Close

$0.04

Daily Range

$0.04 - $0.04

52-Week Range

$0.04 - $0.55

Estimated Earnings Date

Sep 24, 2026

PHRRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaTher

Industry

Pharmaceuticals

CEO

Fabio Chianelli

Headquarters

Toronto, ON M5C 1P1, CA

PHRRF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-128%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-20.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.83M

Shares Outstanding

91.02M

Volume

113.40K

Avg. Volume

207.83K

Financials (TTM)

Gross Profit

CA$0.00

Operating Income

-CA$1.52M

EBITDA

-CA$1.52M

Operating Cash Flow

-CA$1.21M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.21M

Cash & ST Invst.

CA$1.12M

Total Debt

CA$0.00

PharmaTher Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

CA$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.83M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-CA$2.36K

+99.4%

EBITDA

-CA$212.43K

+40.6%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$861.39K

-33.3%

Total Debt

CA$0.00

N/A

Accounts Receivable

CA$8.31K

-48.0%

Inventory

CA$0.00

N/A

Long Term Debt

CA$0.00

N/A

Short Term Debt

CA$0.00

N/A

Return on Assets

-1.03%

N/A

Return on Invested Capital

-2.41%

N/A

Free Cash Flow

-CA$233.09K

+29.7%

Operating Cash Flow

-CA$233.09K

+29.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIXTBioxytran, Inc.
$0.03-8.25%
THERTheralink Technologies, Inc.
$0.00+0.00%
NSHSFNanoSphere Health Sciences Inc.
$0.01+0.00%
BETRFBetterLife Pharma Inc.
$0.05-4.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$160.95+0.19%
AALAmerican Airlines Group
$14.98+0.02%
INTCIntel
$124.57+0.07%
NOKNokia
$14.80+0.05%

Questions About PHRRF

What is the current price of PharmaTher?

PharmaTher is trading at $0.04 per share.

What is the 52-week range for PharmaTher?

Over the past 52 weeks, PharmaTher has traded between $0.04 and $0.55.

How much debt does PharmaTher have?

As of the most recent reporting period, PharmaTher reported total debt of CA$0.00.

How much cash does PharmaTher have on hand?

PharmaTher reported CA$582.76K in cash and cash equivalents in its most recent financial results.

What is PharmaTher’s dividend yield?

PharmaTher does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.